Results 101 to 110 of about 13,250 (212)

A Fully Decentralized Randomized Controlled Study of As-Needed Albuterol–Budesonide Fixed-Dose Inhaler in Mild Asthma: The BATURA Study Design

Journal of Asthma and Allergy
Craig LaForce,1 Frank C Albers,2 Mark Cooper,3 Anna Danilewicz,4 Lynn Dunsire,3 Robert Rees,4 Christy Cappelletti5 1North Carolina Clinical Research, Chapel Hill, NC, USA; 2Avillion, Northbrook, IL, USA; 3BioPharmaceuticals Research and Development ...
LaForce C, Albers FC, Cooper M, Danilewicz A, Dunsire L, Rees R, Cappelletti C   +6 more
doaj  

Determination of Albuterol in Bulk and Dosage Form by UV-Visible Spectroscopy using Buffer-Ethanol System

, 2019
A novel, simple, accurate and precise UV-visible spectroscopic method for determination albuterol in buffer-ethanol (1:1) system has been developed and validated.
Phanasekar, Prashant G, Sharma, Pushpendra   +1 more
core   +1 more source

NEDOCROMIL SODIUM VERSUS ALBUTEROL IN THE MANAGEMENT OF ALLERGIC-ASTHMA

, 1994
In a double-blind, double-placebo, randomized crossover study, we compared the effects of 6 wk of treatment with the anti-inflammatory drug nedocromil sodium (16 mg/day) with 6 wk of treatment with the bronchodilator drug albuterol (800 mu g/day) in 29 ...
TEENGS, JP, KOETER, GH, POSTMA, DS, VANDERMARK, TW, DEJONG, JW, DEMONCHY, JGR   +5 more
core   +1 more source

Cost Avoidance of Using an Automatic Therapeutic Interchange of Racemic Albuterol in Place of Levalbuterol

, 2013
Purpose: To determine if any cost avoidance would occur by utilizing an automatic therapeutic interchange of racemic albuterol for levalbuterol in a health system.
Holaway, Christopher S, Weinhold, Chad
core  

Albuterol-induced downregulation of Gsα accounts for pulmonary β2- adrenoceptor desensitization in vivo

, 2000
The aim of the present study was to develop a chronic in vivo model of pulmonary β2-adrenoceptor desensitization and to elucidate the nature and molecular basis of this state.
Belvisi, MG, Judith C.W. Mak, Ian M. Adcock, Mark A. Giembycz, Barnes, PJ, Paul A. Finney, Scorer, C, Giembycz, MA, Peter J. Barnes, Finney, PA, Tsu-Tshen Chuang, Carol Scorer, Mak, JCW, Maria G. Belvisi, Donnelly, LE, Chuang, TT, Adcock, IM, Louise E. Donnelly   +17 more
core   +1 more source

Bronchodilator reversibility in patients with COPD revisited: short-term reproducibility

International Journal of COPD, 2016
Steven Pascoe,1 Wei Wu,2 Chang-Qing Zhu,3 Dave Singh4 1GSK, Respiratory Medicines Development Center, 2PAREXEL International, Research Triangle Park, NC, USA; 3GSK, Clinical Statistics (Respiratory), Middlesex, UK; 4Medicines Evaluation Unit, University
Pascoe S, Wu W, Zhu CQ, Singh D
doaj  

Levalbuterol is as effective as racemic albuterol in lowering serum potassium.

, 2003
Albuterol is an effective treatment for hyperkalemia through beta-adrenergic induction of potassium (K+) uptake. Levalbuterol, the R-enantiomer of racemic albuterol, is used for the treatment of asthma and 0.63 mg of levalbuterol has the same therapeutic
Reed, James, Pancu, Diana, LaFlamme, Michelle, Evans, Elizabeth M, DO   +3 more
core  

Disease Burden of Asthma Patients Utilizing Short-Acting Beta-2 Agonist-Only Inhalers as Rescue in the United States

Journal of Asthma and Allergy
Njira Lugogo,1 Rena C Moon,2 Yen Chung,3 Joy David,2 Omar Motawakel,3 Ning A Rosenthal,2 Neil Skolnik4 1Pulmonary & Critical Care Medicine, University of Michigan Health, Ann Arbor, MI, USA; 2Premier Applied Sciences, Premier Inc, Charlotte, NC, USA;
Lugogo N, Moon RC, Chung Y, David J, Motawakel O, Rosenthal NA, Skolnik N   +6 more
doaj  

Subject-Specific Whole-Lung CFPD Coupled with PBPK/PD to Predict Inhaled Bronchodilator Response in Asthmatic and Healthy Subjects. [PDF]

J Aerosol Sci
Rajaraman PK, Zhang X, Comellas AP, Hoffman EA, Lin CL.   +4 more
europepmc   +1 more source

A randomized, masked, crossover, clinical trial of the efficacy and safety of nebulized albuterol sulfate and dexamethasone sodium phosphate in asthmatic horses. [PDF]

J Vet Intern Med
Tyson KN, Couetil LL, Ivester KM, Murray L, Mukhopadhyay A, Marmolejo JF, Jannasch A.   +6 more
europepmc   +1 more source